Kathmere Capital Management, LLC Pfizer Inc Transaction History

Kathmere Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$25.89 - $29.73 $107,158 - $123,052	-4,139 Reduced 36.12%	7,321 $203,000
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $134,585 - $157,316	4,194 Added 57.72%	11,460 $380,000
Q2 2023 Jul 11, 2023	BUY	$36.12 - $41.79 $262,447 - $303,646	7,266 New	7,266 $266,000
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $7,556 - $9,864	181 Added 3.45%	5,420 $0
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $22,920 - $29,920	-549 Reduced 9.49%	5,239 $0
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $25,555 - $31,197	584 Added 11.22%	5,788 $253,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $20,426 - $24,219	439 Added 9.21%	5,204 $273,000
Q1 2022 Apr 28, 2022	BUY	$45.75 - $56.69 $217,998 - $270,127	4,765 New	4,765 $247,000
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $55,358 - $62,433	-1,653 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $33,470 - $42,560	1,000 Added 153.14%	1,653 $61,000
Q3 2020 Nov 20, 2020	SELL	$31.75 - $37.25 $1.54 Million - $1.8 Million	-48,424 Reduced 98.67%	653 $24,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.56 Million - $1.83 Million	49,077 New	49,077 $1.79 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kathmere Capital Management, LLC with notifications on news.